{"podcast":{"title":"The IMID Forum","slug":"the-imid-forum-981476","podcast_index_feed_id":981476,"rss_url":"https://feeds.soundcloud.com/users/soundcloud:users:176191917/sounds.rss","website_url":"https://imidforum.com/","image_url":"https://i1.sndcdn.com/avatars-OaKRAwW87iY4HNbI-rfRlqw-original.jpg","author":"The Immune-Mediated Inflammatory Disease Forum","episode_count":414,"summary":"Keeping you up to date with the latest and most i…","last_synced_at":"2026-07-30T22:18:23.232091+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476"},"episodes":[{"title":"Discussing RA: Advanced therapy outcomes in RA","slug":"discussing-ra-advanced-therapy-outcomes-in-ra","published_at":"2026-07-30T11:03:38+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-ra-advanced-therapy-outcomes-in-ra","url":"https://soundcloud.com/imidforum/discussing-ra-advanced-therapy","duration_seconds":1646,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-ra-advanced-therapy-outcomes-in-ra/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-ra-advanced-therapy-outcomes-in-ra.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Author Interview: Professor Laura Coates, July 2026","slug":"author-interview-professor-laura-coates-july-2026","published_at":"2026-07-22T13:35:34+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/author-interview-professor-laura-coates-july-2026","url":"https://soundcloud.com/imidforum/author-interview-professor-3","duration_seconds":1605,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/author-interview-professor-laura-coates-july-2026/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/author-interview-professor-laura-coates-july-2026.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Discussing axSpA: Long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA","slug":"discussing-axspa-long-term-safety-and-efficacy-of-bimekizumab-and-ixekizumab-in-r-axspa","published_at":"2026-07-16T13:30:54+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-axspa-long-term-safety-and-efficacy-of-bimekizumab-and-ixekizumab-in-r-axspa","url":"https://soundcloud.com/imidforum/discussing-axspa-long-term","duration_seconds":1428,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-axspa-long-term-safety-and-efficacy-of-bimekizumab-and-ixekizumab-in-r-axspa/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-axspa-long-term-safety-and-efficacy-of-bimekizumab-and-ixekizumab-in-r-axspa.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Author Interview: Dr Murat Torgutalp, June 2026","slug":"author-interview-dr-murat-torgutalp-june-2026","published_at":"2026-07-09T11:32:43+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/author-interview-dr-murat-torgutalp-june-2026","url":"https://soundcloud.com/imidforum/author-interview-dr-murat","duration_seconds":1767,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/author-interview-dr-murat-torgutalp-june-2026/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/author-interview-dr-murat-torgutalp-june-2026.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Discussing RA: Infectious complications of RA treatments","slug":"discussing-ra-infectious-complications-of-ra-treatments","published_at":"2026-06-25T09:49:32+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-ra-infectious-complications-of-ra-treatments","url":"https://soundcloud.com/imidforum/discussing-ra-infectious","duration_seconds":584,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-ra-infectious-complications-of-ra-treatments/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-ra-infectious-complications-of-ra-treatments.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Author Interview: Doctor Chung-Mao Kao, May 2026","slug":"author-interview-doctor-chung-mao-kao-may-2026","published_at":"2026-06-23T13:27:10+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/author-interview-doctor-chung-mao-kao-may-2026","url":"https://soundcloud.com/imidforum/author-interview-doctor-chung","duration_seconds":829,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/author-interview-doctor-chung-mao-kao-may-2026/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/author-interview-doctor-chung-mao-kao-may-2026.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Discussing PsA: Personalising treatment targets – understanding clinically meaningful improvement","slug":"discussing-psa-personalising-treatment-targets-understanding-clinically-meaningful-improvement","published_at":"2026-06-18T08:28:19+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-psa-personalising-treatment-targets-understanding-clinically-meaningful-improvement","url":"https://soundcloud.com/imidforum/discussing-psa-personalising","duration_seconds":783,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-psa-personalising-treatment-targets-understanding-clinically-meaningful-improvement/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-psa-personalising-treatment-targets-understanding-clinically-meaningful-improvement.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"EULAR 2026 Review Podcast","slug":"eular-2026-review-podcast","published_at":"2026-06-12T10:25:39+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/eular-2026-review-podcast","url":"https://soundcloud.com/imidforum/eular-2026-review-podcast","duration_seconds":2376,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/eular-2026-review-podcast/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/eular-2026-review-podcast.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"EULAR 2026 Day 4 Highlights Podcast","slug":"eular-2026-day-4-highlights-podcast","published_at":"2026-06-06T06:00:33+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/eular-2026-day-4-highlights-podcast","url":"https://soundcloud.com/imidforum/eular-2026-day-4-highlights","duration_seconds":290,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/eular-2026-day-4-highlights-podcast/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/eular-2026-day-4-highlights-podcast.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"EULAR 2026 Day 3 Highlights Podcast","slug":"eular-2026-day-3-highlights-podcast","published_at":"2026-06-05T06:00:33+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/eular-2026-day-3-highlights-podcast","url":"https://soundcloud.com/imidforum/eular-2026-day-3-highlights","duration_seconds":206,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/eular-2026-day-3-highlights-podcast/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/eular-2026-day-3-highlights-podcast.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"EULAR 2026 Day 2 Highlights Podcast","slug":"eular-2026-day-2-highlights-podcast","published_at":"2026-06-04T06:00:43+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/eular-2026-day-2-highlights-podcast","url":"https://soundcloud.com/imidforum/eular-2026-day-2-highlights","duration_seconds":332,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/eular-2026-day-2-highlights-podcast/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/eular-2026-day-2-highlights-podcast.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"EULAR 2025 Day 1 Highlights Podcast","slug":"eular-2025-day-1-highlights-podcast","published_at":"2026-06-03T06:00:23+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/eular-2025-day-1-highlights-podcast","url":"https://soundcloud.com/imidforum/eular-2025-day-1-highlights","duration_seconds":337,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/eular-2025-day-1-highlights-podcast/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/eular-2025-day-1-highlights-podcast.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Discussing RA: Comparative outcomes with upadacitinib in RA","slug":"discussing-ra-comparative-outcomes-with-upadacitinib-in-ra","published_at":"2026-05-28T11:04:50+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-ra-comparative-outcomes-with-upadacitinib-in-ra","url":"https://soundcloud.com/imidforum/discussing-ra-comparative","duration_seconds":513,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-ra-comparative-outcomes-with-upadacitinib-in-ra/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-ra-comparative-outcomes-with-upadacitinib-in-ra.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"EULAR 2026 Preview Podcast","slug":"eular-2026-preview-podcast","published_at":"2026-05-27T14:49:33+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/eular-2026-preview-podcast","url":"https://soundcloud.com/imidforum/eular-2025-preview-podcast-1","duration_seconds":1344,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/eular-2026-preview-podcast/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/eular-2026-preview-podcast.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Discussing axSpA: Biologic therapy outcomes in axial spondyloarthritis","slug":"discussing-axspa-biologic-therapy-outcomes-in-axial-spondyloarthritis","published_at":"2026-05-15T10:59:08+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-axspa-biologic-therapy-outcomes-in-axial-spondyloarthritis","url":"https://soundcloud.com/imidforum/discussing-axspa-biologic","duration_seconds":1315,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-axspa-biologic-therapy-outcomes-in-axial-spondyloarthritis/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-axspa-biologic-therapy-outcomes-in-axial-spondyloarthritis.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Author Interview: Professor Valentino Paci, April 2026","slug":"author-interview-professor-valentino-paci-april-2026","published_at":"2026-04-30T14:30:37+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/author-interview-professor-valentino-paci-april-2026","url":"https://soundcloud.com/imidforum/author-interview-professor-2","duration_seconds":2426,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/author-interview-professor-valentino-paci-april-2026/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/author-interview-professor-valentino-paci-april-2026.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Discussing RA: Updated EULAR recommendations and next-step strategies after TNF inhibitor failure","slug":"discussing-ra-updated-eular-recommendations-and-next-step-strategies-after-tnf-inhibitor-failure","published_at":"2026-04-30T09:57:39+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-ra-updated-eular-recommendations-and-next-step-strategies-after-tnf-inhibitor-failure","url":"https://soundcloud.com/imidforum/discussing-ra-eular","duration_seconds":868,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-ra-updated-eular-recommendations-and-next-step-strategies-after-tnf-inhibitor-failure/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-ra-updated-eular-recommendations-and-next-step-strategies-after-tnf-inhibitor-failure.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Discussing PsA: Bimekizumab in PsA: Clinical efficacy and updated safety profile","slug":"discussing-psa-bimekizumab-in-psa-clinical-efficacy-and-updated-safety-profile","published_at":"2026-04-14T13:31:19+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-psa-bimekizumab-in-psa-clinical-efficacy-and-updated-safety-profile","url":"https://soundcloud.com/imidforum/discussing-psa-bimekizumab-in","duration_seconds":992,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-psa-bimekizumab-in-psa-clinical-efficacy-and-updated-safety-profile/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-psa-bimekizumab-in-psa-clinical-efficacy-and-updated-safety-profile.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Author Interview: Professor Helena Marzo-Ortega, March 2026","slug":"author-interview-professor-helena-marzo-ortega-march-2026","published_at":"2026-04-09T14:08:14+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/author-interview-professor-helena-marzo-ortega-march-2026","url":"https://soundcloud.com/imidforum/author-interview-professor-1","duration_seconds":2259,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/author-interview-professor-helena-marzo-ortega-march-2026/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/author-interview-professor-helena-marzo-ortega-march-2026.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Discussing RA: Malignancy risk in patients with RA and the evolution of JAKi prescriptions","slug":"discussing-ra-malignancy-risk-in-patients-with-ra-and-the-evolution-of-jaki-prescriptions","published_at":"2026-03-26T10:45:45+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-ra-malignancy-risk-in-patients-with-ra-and-the-evolution-of-jaki-prescriptions","url":"https://soundcloud.com/imidforum/discussing-ra-malignancy-risk","duration_seconds":602,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-ra-malignancy-risk-in-patients-with-ra-and-the-evolution-of-jaki-prescriptions/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-ra-malignancy-risk-in-patients-with-ra-and-the-evolution-of-jaki-prescriptions.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Discussing axSpA: Symptom duration impact on bimekizumab efficacy and therapeutic switching drivers","slug":"discussing-axspa-symptom-duration-impact-on-bimekizumab-efficacy-and-therapeutic-switching-drivers","published_at":"2026-03-19T11:00:28+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-axspa-symptom-duration-impact-on-bimekizumab-efficacy-and-therapeutic-switching-drivers","url":"https://soundcloud.com/imidforum/discussing-axspa-symptom","duration_seconds":2009,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-axspa-symptom-duration-impact-on-bimekizumab-efficacy-and-therapeutic-switching-drivers/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-axspa-symptom-duration-impact-on-bimekizumab-efficacy-and-therapeutic-switching-drivers.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Author Interview: Doctor Carlo Tur, February 2026","slug":"author-interview-doctor-carlo-tur-february-2026","published_at":"2026-03-12T11:23:16+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/author-interview-doctor-carlo-tur-february-2026","url":"https://soundcloud.com/imidforum/author-interview-doctor-carlo","duration_seconds":1775,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/author-interview-doctor-carlo-tur-february-2026/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/author-interview-doctor-carlo-tur-february-2026.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Author Interview - Professor Andrew Cope, 2026","slug":"author-interview-professor-andrew-cope-2026","published_at":"2026-03-05T11:30:56+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/author-interview-professor-andrew-cope-2026","url":"https://soundcloud.com/imidforum/author-interview-professor","duration_seconds":1490,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/author-interview-professor-andrew-cope-2026/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/author-interview-professor-andrew-cope-2026.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Discussing RA: Pain outcomes and drug effectiveness of JAK inhibitors in RA and PsA","slug":"discussing-ra-pain-outcomes-and-drug-effectiveness-of-jak-inhibitors-in-ra-and-psa","published_at":"2026-02-27T13:04:39+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-ra-pain-outcomes-and-drug-effectiveness-of-jak-inhibitors-in-ra-and-psa","url":"https://soundcloud.com/imidforum/discussing-ra-pain-outcomes","duration_seconds":518,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-ra-pain-outcomes-and-drug-effectiveness-of-jak-inhibitors-in-ra-and-psa/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-ra-pain-outcomes-and-drug-effectiveness-of-jak-inhibitors-in-ra-and-psa.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Discussing PsA: Risankizumab efficacy across machine learning defined and complex PsA phenotypes","slug":"discussing-psa-risankizumab-efficacy-across-machine-learning-defined-and-complex-psa-phenotypes","published_at":"2026-02-13T15:00:24+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-psa-risankizumab-efficacy-across-machine-learning-defined-and-complex-psa-phenotypes","url":"https://soundcloud.com/imidforum/discussing-psa-risankizumab","duration_seconds":1250,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-psa-risankizumab-efficacy-across-machine-learning-defined-and-complex-psa-phenotypes/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-psa-risankizumab-efficacy-across-machine-learning-defined-and-complex-psa-phenotypes.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Author Interview: Professor Matthew Brown, 2026","slug":"author-interview-professor-matthew-brown-2026","published_at":"2026-02-03T14:36:46+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/author-interview-professor-matthew-brown-2026","url":"https://soundcloud.com/imidforum/author-interview-professor-matthew-brown-2026","duration_seconds":1109,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/author-interview-professor-matthew-brown-2026/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/author-interview-professor-matthew-brown-2026.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Discussing RA: Long-term effectiveness and sex differences of JAK inhibitors in rheumatoid arthritis","slug":"discussing-ra-long-term-effectiveness-and-sex-differences-of-jak-inhibitors-in-rheumatoid-arthritis","published_at":"2026-01-29T14:42:37+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-ra-long-term-effectiveness-and-sex-differences-of-jak-inhibitors-in-rheumatoid-arthritis","url":"https://soundcloud.com/imidforum/discussing-ra-long-term-effectiveness-and-sex-differences-of-jak-inhibitors-in-rheumatoid-arthritis","duration_seconds":560,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-ra-long-term-effectiveness-and-sex-differences-of-jak-inhibitors-in-rheumatoid-arthritis/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-ra-long-term-effectiveness-and-sex-differences-of-jak-inhibitors-in-rheumatoid-arthritis.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Discussing RA: UPA outcomes and the impact of GCs on targeted therapies in RA","slug":"discussing-ra-upa-outcomes-and-the-impact-of-gcs-on-targeted-therapies-in-ra","published_at":"2025-12-18T14:52:48+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-ra-upa-outcomes-and-the-impact-of-gcs-on-targeted-therapies-in-ra","url":"https://soundcloud.com/imidforum/discussing-ra-upa-outcomes-and-the-impact-of-gcs-on-targeted-therapies-in-ra","duration_seconds":1350,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-ra-upa-outcomes-and-the-impact-of-gcs-on-targeted-therapies-in-ra/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-ra-upa-outcomes-and-the-impact-of-gcs-on-targeted-therapies-in-ra.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Discussing axSpA: Real-world outcomes for patients with axSpA receiving SC infliximab","slug":"discussing-axspa-real-world-outcomes-for-patients-with-axspa-receiving-sc-infliximab","published_at":"2025-12-11T11:30:00+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-axspa-real-world-outcomes-for-patients-with-axspa-receiving-sc-infliximab","url":"https://soundcloud.com/imidforum/discussing-axspa-real-world-outcomes-for-patients-with-axspa-receiving-sc-infliximab","duration_seconds":788,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-axspa-real-world-outcomes-for-patients-with-axspa-receiving-sc-infliximab/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-axspa-real-world-outcomes-for-patients-with-axspa-receiving-sc-infliximab.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Discussing PsA: Uveitis risk and treatment sequencing outcomes in axSpa and PsA","slug":"discussing-psa-uveitis-risk-and-treatment-sequencing-outcomes-in-axspa-and-psa","published_at":"2025-12-04T09:00:03+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-psa-uveitis-risk-and-treatment-sequencing-outcomes-in-axspa-and-psa","url":"https://soundcloud.com/imidforum/discussing-psa-uveitis-risk-and-treatment-sequencing-outcomes-in-axspa-and-psa","duration_seconds":1247,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-psa-uveitis-risk-and-treatment-sequencing-outcomes-in-axspa-and-psa/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-psa-uveitis-risk-and-treatment-sequencing-outcomes-in-axspa-and-psa.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Discussing RA: Real-world evaluation of JAKi efficacy, persistence, and cardiovascular safety in RA","slug":"discussing-ra-real-world-evaluation-of-jaki-efficacy-persistence-and-cardiovascular-safety-in-ra","published_at":"2025-11-27T08:59:13+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-ra-real-world-evaluation-of-jaki-efficacy-persistence-and-cardiovascular-safety-in-ra","url":"https://soundcloud.com/imidforum/discussing-ra-real-world-evaluation-of-jaki-efficacy-persistence-and-cardiovascular-safety-in-ra","duration_seconds":585,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-ra-real-world-evaluation-of-jaki-efficacy-persistence-and-cardiovascular-safety-in-ra/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-ra-real-world-evaluation-of-jaki-efficacy-persistence-and-cardiovascular-safety-in-ra.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Author Interview: Professor Filip Rob, 2025","slug":"author-interview-professor-filip-rob-2025","published_at":"2025-11-20T09:00:09+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/author-interview-professor-filip-rob-2025","url":"https://soundcloud.com/imidforum/author-interview-professor-filip-rob-2025","duration_seconds":1507,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/author-interview-professor-filip-rob-2025/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/author-interview-professor-filip-rob-2025.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Webinar Highlights: Advancing Patient Care Through an Interdisciplinary Approach to IMIDs: Part 2","slug":"webinar-highlights-advancing-patient-care-through-an-interdisciplinary-approach-to-imids-part-2","published_at":"2025-11-16T20:49:06+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/webinar-highlights-advancing-patient-care-through-an-interdisciplinary-approach-to-imids-part-2","url":"https://soundcloud.com/imidforum/webinar-highlights-advancing-patient-care-through-an-interdisciplinary-approach-to-imids-part-2","duration_seconds":1022,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/webinar-highlights-advancing-patient-care-through-an-interdisciplinary-approach-to-imids-part-2/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/webinar-highlights-advancing-patient-care-through-an-interdisciplinary-approach-to-imids-part-2.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Discussing axSpA: Adalimumab dosing and uveitis recurrence in patients with ankylosing spondylitis","slug":"discussing-axspa-adalimumab-dosing-and-uveitis-recurrence-in-patients-with-ankylosing-spondylitis","published_at":"2025-11-13T09:04:18+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-axspa-adalimumab-dosing-and-uveitis-recurrence-in-patients-with-ankylosing-spondylitis","url":"https://soundcloud.com/imidforum/discussing-axspa-adalimumab-dosing-and-uveitis-recurrence-in-patients-with-ankylosing-spondylitis","duration_seconds":877,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-axspa-adalimumab-dosing-and-uveitis-recurrence-in-patients-with-ankylosing-spondylitis/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-axspa-adalimumab-dosing-and-uveitis-recurrence-in-patients-with-ankylosing-spondylitis.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Discussing RA: Long-term management of elderly patients with RA treated with tocilizumab","slug":"discussing-ra-long-term-management-of-elderly-patients-with-ra-treated-with-tocilizumab","published_at":"2025-11-06T09:11:14+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-ra-long-term-management-of-elderly-patients-with-ra-treated-with-tocilizumab","url":"https://soundcloud.com/imidforum/discussing-ra-long-term-management-of-elderly-patients-with-ra-treated-with-tocilizumab","duration_seconds":315,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-ra-long-term-management-of-elderly-patients-with-ra-treated-with-tocilizumab/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-ra-long-term-management-of-elderly-patients-with-ra-treated-with-tocilizumab.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"ACR 2025 Review Podcast","slug":"acr-2025-review-podcast","published_at":"2025-11-05T11:33:35+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/acr-2025-review-podcast","url":"https://soundcloud.com/imidforum/acr-2025-review-podcast","duration_seconds":2415,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/acr-2025-review-podcast/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/acr-2025-review-podcast.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"ACR Daily Highlights Day 4","slug":"acr-daily-highlights-day-4","published_at":"2025-10-29T13:00:39+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/acr-daily-highlights-day-4","url":"https://soundcloud.com/imidforum/acr-daily-highlights-day-4","duration_seconds":108,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/acr-daily-highlights-day-4/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/acr-daily-highlights-day-4.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}]}